RMG Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$27.1K Buy
21
+2
+11% +$2.36K ﹤0.01% 217
2026
Q2
$23.2K Hold
19
– – ﹤0.01% 220
2026
Q1
$18.4K Hold
19
– – ﹤0.01% 240
2025
Q4
$20.7K Buy
+19
New +$18.2K ﹤0.01% 207

Other funds holding LLY

RMG Wealth Management's LLY Position: Q3 2026 in Review

RMG Wealth Management increased its Eli Lilly (LLY) stake by 11% in Q3 2026, buying an estimated $2.36K and bringing the position to 21 shares worth $27.1K. The position accounts for ﹤0.01% of the portfolio, ranked #217.

RMG Wealth Management first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. 1,741 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • RMG Wealth Management held 21 shares of Eli Lilly worth $27.1K as of Q3 2026.
  • RMG Wealth Management bought 2 Eli Lilly shares in Q3 2026, an estimated $2.36K.
  • Eli Lilly made up ﹤0.01% of RMG Wealth Management's portfolio in Q3 2026, its #217 holding.
  • RMG Wealth Management first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • 1,741 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on RMG Wealth Management's 13F filing for Q3 2026, filed 26 Oct 2026.